[None None Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 135,487,408 Ordinary Shares Issued and Outstanding ¨ x ¨ x x ¨ x ¨ ¨ Large accelerated filer x Accelerated filer ¨ Non-accelerated filer x U.S. GAAP International Financial] [• Ascendium Group Limited (incorporated in the British Virgin Islands) • Our Medical Services, Ltd. (incorporated in the British Virgin Islands) • US Proton Therapy Holdings Limited (incorporated in the British Virgin Islands) • Medstar Overseas Ltd. (incorporated in the British Virgin Islands) • US Proton Therapy Holdings Limited (Delaware) (incorporated in Delaware, USA) • China Medical Services Holdings Limited] [Certification by the Chief Executive Officer I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification by the Chief Financial Officer I, Adam Jigang Sun, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 5 d526377dex131.htm EX-13.1] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 6 d526377dex132.htm EX-13.2]